IRTC iRhythm Technologies, Inc.
Healthcare$114.45-1.81%ClosedMarket Cap: $3.76B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
23.50
P/S
4.86
EV/EBITDA
899.73
DCF Value
$80.92
FCF Yield
0.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
71.0%
Operating Margin
-2.7%
Net Margin
-3.5%
ROE
-20.6%
ROA
-2.8%
ROIC
-2.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $199.4M | 70.9% | $-11.9M | $-13.9M | $— | — |
| Q4 null | $208.9M | 70.9% | $8.8M | $5.6M | $— | — |
| FY null | $747.1M | 70.6% | $-36.8M | $-44.6M | $— | — |
| Q3 null | $192.9M | 71.1% | $-4.0M | $-5.2M | $— | — |
| Q2 null | $186.7M | 71.2% | $-14.5M | $-14.2M | $— | — |
| Q1 null | $158.7M | 68.8% | $-32.3M | $-30.7M | $— | — |
| Q4 null | $164.3M | 70.0% | $-4.1M | $-1.3M | $— | — |
| FY null | $591.8M | 68.9% | $-115.5M | $-113.3M | $— | — |
| Q3 null | $147.5M | 68.8% | $-50.3M | $-46.2M | $— | — |
| Q2 null | $148.0M | 69.9% | $-23.0M | $-20.1M | $— | — |
| Q1 null | $131.9M | 66.3% | $-38.1M | $-45.7M | $— | — |
| Q4 2023 | $132.5M | 66.0% | $-39.2M | $-38.7M | $-1.26 | — |